Cite
IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway.
MLA
Galéa, P., et al. “IL-4, but Not Tumor Necrosis Factor-Alpha, Increases Endothelial Cell Adhesiveness for Lymphocytes by Activating a CAMP-Dependent Pathway.” Journal of Immunology (Baltimore, Md. : 1950), vol. 151, no. 2, July 1993, pp. 588–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=7687617&authtype=sso&custid=ns315887.
APA
Galéa, P., Thibault, G., Lacord, M., Bardos, P., & Lebranchu, Y. (1993). IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. Journal of Immunology (Baltimore, Md. : 1950), 151(2), 588–596.
Chicago
Galéa, P, G Thibault, M Lacord, P Bardos, and Y Lebranchu. 1993. “IL-4, but Not Tumor Necrosis Factor-Alpha, Increases Endothelial Cell Adhesiveness for Lymphocytes by Activating a CAMP-Dependent Pathway.” Journal of Immunology (Baltimore, Md. : 1950) 151 (2): 588–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=7687617&authtype=sso&custid=ns315887.